MARKET

UTHR

UTHR

United Therapeutics Corp.
NASDAQ
522.83
-9.70
-1.82%
After Hours: 522.83 0 0.00% 16:57 03/27 EDT
OPEN
534.11
PREV CLOSE
532.53
HIGH
535.33
LOW
520.97
VOLUME
338.24K
TURNOVER
--
52 WEEK HIGH
549.50
52 WEEK LOW
266.98
MARKET CAP
22.91B
P/E (TTM)
18.76
1D
5D
1M
3M
1Y
5Y
1D
United Therapeutics; Chairperson and CEO Martine A. Rothblatt reports common stock disposal worth $5,200,000
Reuters · 1d ago
James Edgemond, CFO and Treasurer; disposes of United Therapeutics common shares worth $5,793,000
Reuters · 1d ago
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?
NASDAQ · 1d ago
United Therapeutics Insider Makes Eye‑Catching Move With Fresh Stock Sale
TipRanks · 1d ago
United Therapeutics Chairperson and CEO Martine A. Rothblatt disposes of common shares; $2,000,000 falls in proceeds
Reuters · 2d ago
United Therapeutics; Director Tommy G Thompson disposes of $1,081,000 in common shares
Reuters · 2d ago
Liquidia: Yutrepia Has Impressed, But Here's Why I Remain Cautious (Rating Upgrade)
Seeking Alpha · 2d ago
United Therapeutics Chairperson and CEO Martine A. Rothblatt disposes of common shares; $6,012,000 drops in value
Reuters · 3d ago
More
About UTHR
United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder product.

Webull offers United Therapeutics Corp stock information, including NASDAQ: UTHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UTHR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UTHR stock methods without spending real money on the virtual paper trading platform.